Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Oramed Pharmaceuticals Q3 EPS $(0.18) Down From $(0.17) YoY

Oramed Pharmaceuticals Q3 EPS $(0.18) Down From $(0.17) YoY

Oramed Pharmaceuticals (NASDAQ:ORMP) reported quarterly losses of $(0.18) per share. This is a 5.88 percent decrease over losses of $(0.17) per share from the same period last year.

byBenzinga Newsdesk

November 10, 2022

1 minute read

Oramed Pharmaceuticals (NASDAQ:ORMP) reported quarterly losses of $(0.18) per share. This is a 5.88 percent decrease over losses of $(0.17) per share from the same period last year.

News

What In The World Is Going On With Dogecoin?

By Henry Khederian

April 6, 11:24 PM

Dogecoin (CRYPTO: DOGE) has surged 8.3% to reach the $0.196-level on Saturday, marking a notable rebound from weakness experienced earlier this week.

$DOGE

BeReal-ity Check! Social Media App Is Dubbed A Threat To Instagram, TikTok But There Is More To The Story Than 50M Downloads

By Ananya Gairola

October 11, 2:57 AM

BeReal, a social media app that encourages users to take a photo every day in an effort to create a daily habit, has amassed more than 53 million downloads across Apple Inc.’s (NASDAQ: AAPL) iOS App Store and Alphabet Inc.’s (NASDAQ:

AAPL